Literature DB >> 28490491

Comparison of the Vitek MS and Bruker Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Systems for Identification of Rhodococcus equi and Dietzia spp.

Carlos Ruiz de Alegría Puig1, Lilian Pilares2, Francesc Marco3, Jordi Vila3, Luis Martínez-Martínez4, Jesús Navas2.   

Abstract

Rhodococcus equi causes pyogranulomatous pneumonia in domesticated animals and immunocompromised humans. Dietzia spp. are environmental bacteria that have rarely been associated with human infections. R. equi and Dietzia spp. are closely related actinomycetes. Phenotypic discrimination between R. equi and Dietzia on the basis of their Gram stain morphology and colony appearance is problematic. Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) is a fast, reliable, and cost-effective method for identification of a wide variety of microorganisms. We have evaluated the performance of Bruker Biotyper versus that of Vitek MS for identification of a collection of 154 isolates identified at the source as R. equi that includes isolates belonging to the genus Dietzia PCR amplification of the choE gene, encoding a cholesterol oxidase, and 16S rRNA sequencing were considered the reference methods for R. equi identification. Biotyper identified 131 (85.1%) of the 154 isolates at the species level, and this figure increased to 152 (98.7%) when the species cutoff was reduced from a score of ≥2.000 to ≥1.750. Vitek MS correctly identified at the species level 130 (84.4%) isolates as long as bacteria were extracted with ethanol but only 35 (22.7%) isolates when samples were prepared by direct extraction from colonies. The two systems allowed differentiation between R. equi and Dietzia spp., but identification of all Dietzia sp. isolates at the species level needed sequencing of the 16S rRNA gene.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Dietzia spp.; MALDI-TOF MS; Rhodococcus equi; genotypic identification; identification

Mesh:

Substances:

Year:  2017        PMID: 28490491      PMCID: PMC5483928          DOI: 10.1128/JCM.00377-17

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Bacteremia due to Dietzia maris in an immunocompromised patient.

Authors:  P Bemer-Melchior; A Haloun; P Riegel; H B Drugeon
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

Review 2.  Clinical manifestations, diagnosis, treatment, and prevention of Rhodococcus equi infections in foals.

Authors:  S Giguère; J F Prescott
Journal:  Vet Microbiol       Date:  1997-06-16       Impact factor: 3.293

Review 3.  Rhodococcus equi: the many facets of a pathogenic actinomycete.

Authors:  José A Vázquez-Boland; Steeve Giguère; Alexia Hapeshi; Iain MacArthur; Elisa Anastasi; Ana Valero-Rello
Journal:  Vet Microbiol       Date:  2013-07-05       Impact factor: 3.293

4.  Comparison of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of mycobacteria using simplified protein extraction protocols.

Authors:  Cheryl A Mather; Sheila F Rivera; Susan M Butler-Wu
Journal:  J Clin Microbiol       Date:  2013-10-30       Impact factor: 5.948

5.  Multicenter evaluation of the updated and extended API (RAPID) Coryne database 2.0.

Authors:  G Funke; F N Renaud; J Freney; P Riegel
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

6.  Identification of atypical Rhodococcus-like clinical isolates as Dietzia spp. by 16S rRNA gene sequencing.

Authors:  Lilian Pilares; Jesús Agüero; José A Vázquez-Boland; Luis Martínez-Martínez; Jesús Navas
Journal:  J Clin Microbiol       Date:  2010-03-10       Impact factor: 5.948

7.  Dietzia cinnamea sp. nov., a novel species isolated from a perianal swab of a patient with a bone marrow transplant.

Authors:  A F Yassin; H Hupfer; K P Schaal
Journal:  Int J Syst Evol Microbiol       Date:  2006-03       Impact factor: 2.747

8.  PCR primers and probes for the 16S rRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid.

Authors:  K Greisen; M Loeffelholz; A Purohit; D Leong
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

9.  Identification of Dietzia spp. from Cardiac Tissue by 16S rRNA PCR in a Patient with Culture-Negative Device-Associated Endocarditis: A Case Report and Review of the Literature.

Authors:  Praveen Sudhindra; Guiqing Wang; Robert B Nadelman
Journal:  Case Rep Infect Dis       Date:  2016-12-22

10.  Development and evaluation of the internal-controlled real-time PCR assay for Rhodococcus equi detection in various clinical specimens.

Authors:  Ilona Stefańska; Lucjan Witkowski; Magdalena Rzewuska; Tomasz Dzieciątkowski
Journal:  J Vet Med Sci       Date:  2015-12-08       Impact factor: 1.267

View more
  3 in total

1.  Comparison of the Vitek MS and Bruker Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Systems for Identification of Chryseobacterium Isolates from Clinical Specimens and Report of Uncommon Chryseobacterium Infections in Humans.

Authors:  Jiun-Nong Lin; Shih-Hua Teng; Chung-Hsu Lai; Chih-Hui Yang; Yi-Han Huang; Hsiu-Fang Lin; Hsi-Hsun Lin
Journal:  J Clin Microbiol       Date:  2018-10-25       Impact factor: 5.948

Review 2.  Clinical Mass Spectrometry in the Bioinformatics Era: A Hitchhiker's Guide.

Authors:  Yeow-Kuan Chong; Chi-Chun Ho; Shui-Yee Leung; Susanna K P Lau; Patrick C Y Woo
Journal:  Comput Struct Biotechnol J       Date:  2018-08-28       Impact factor: 7.271

3.  Prevalence and Antimicrobial Susceptibility Patterns of Bacterial Pathogens in Urinary Tract Infections in University Hospital of Campania "Luigi Vanvitelli" between 2017 and 2018.

Authors:  Veronica Folliero; Pina Caputo; Maria Teresa Della Rocca; Annalisa Chianese; Marilena Galdiero; Maria R Iovene; Cameron Hay; Gianluigi Franci; Massimiliano Galdiero
Journal:  Antibiotics (Basel)       Date:  2020-04-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.